Evaluation Safety ,Efficacy Baricitinib Plus Excimer Light Versus Excimer Light Alone in Non Segmental Vitiligo

A Study of AK111 in Healthy Subjects

NCT03622021 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

NCT01490632 ·Status: COMPLETED ·Phase: PHASE2

Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo

NCT00134368 ·Status: COMPLETED ·Phase: PHASE2

A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)

NCT03065556 ·Status: COMPLETED ·Phase: PHASE2

Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

NCT06846541 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis

NCT00539929 ·Status: COMPLETED ·Phase: PHASE2

Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)

NCT03731052 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis

NCT05120297 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects

NCT03018509 ·Status: COMPLETED ·Phase: PHASE1

A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis

NCT00399906 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)

NCT06113471 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis

NCT03759197 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

NCT03358290 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

NCT07024602 ·Status: RECRUITING ·Phase: PHASE1

Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With Psoriasis

NCT05509361 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

NCT01313221 ·Status: COMPLETED ·Phase: PHASE3

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03410992 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis

NCT01510951 ·Status: COMPLETED ·Phase: PHASE1

A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis

NCT01700985 ·Status: COMPLETED ·Phase: PHASE2

Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study

NCT01522742 ·Status: TERMINATED

A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis.

NCT05965089 ·Status: COMPLETED ·Phase: PHASE1

A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris

NCT03073213 ·Status: COMPLETED ·Phase: PHASE1

A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo

NCT06118411 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Acitretin and Etanercept in Psoriasis

NCT00156247 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis

NCT05600036 ·Status: COMPLETED ·Phase: PHASE2